A halogenobenzylaminopropionic acid derivative represented by the following formula (1): ##STR1##

or a pharmaceutically acceptable salt of the derivative, and a drug containing the same as an active ingredient for treating diabetes, hyperlipidemia, or similar pathological conditions.